ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1,3,Headache,Headaches NEC,Headaches,Nerv,N
1,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5,1,Headache,Headaches NEC,Headaches,Nerv,N
6,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
7,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
7,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
10,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
13,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
13,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
13,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,1,Headache,Headaches NEC,Headaches,Nerv,N
14,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
15,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
16,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
17,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
18,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
18,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,3,Headache,Headaches NEC,Headaches,Nerv,N
18,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
18,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
18,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
18,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
19,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
20,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
20,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
20,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
22,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
22,2,Cor pulmonale,Right ventricular failures,Heart failures,Card,N
23,1,Sweat discolouration,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
24,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
25,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
25,3,Headache,Headaches NEC,Headaches,Nerv,N
25,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,1,Headache,Headaches NEC,Headaches,Nerv,N
26,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
26,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
26,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
27,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
27,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
27,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
29,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
29,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
31,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
32,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
32,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,3,Respiratory tract irritation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
32,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
34,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
34,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
35,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
35,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
36,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
36,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
37,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
37,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
37,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
38,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
38,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
39,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
39,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
40,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
40,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
41,1,Headache,Headaches NEC,Headaches,Nerv,N
41,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
41,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
42,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
42,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
42,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
42,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
43,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
43,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
43,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
44,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
47,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
47,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
48,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
52,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
52,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
54,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
55,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
56,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
56,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
57,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
57,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,1,Headache,Headaches NEC,Headaches,Nerv,N
59,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
60,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
60,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
60,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
61,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
62,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
62,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
62,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
62,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
62,6,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
62,7,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
62,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
63,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Headache,Headaches NEC,Headaches,Nerv,N
65,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
66,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
66,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
67,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,1,Migraine,Migraine headaches,Headaches,Nerv,N
70,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
70,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
71,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
71,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
71,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
71,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,1,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
72,2,Soft tissue swelling,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
73,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
74,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
75,1,Headache,Headaches NEC,Headaches,Nerv,N
75,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
77,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
77,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
78,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
78,3,Tension headache,Headaches NEC,Headaches,Nerv,N
79,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
80,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
81,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
82,1,Headache,Headaches NEC,Headaches,Nerv,N
83,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
88,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,1,Headache,Headaches NEC,Headaches,Nerv,N
90,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,1,Headache,Headaches NEC,Headaches,Nerv,N
92,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
92,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
93,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
94,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
95,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
96,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
97,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,3,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
98,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
100,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
100,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
101,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
101,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
102,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
103,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
103,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
103,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
103,4,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
104,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
104,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
106,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
108,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
109,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
110,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
110,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
110,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
110,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
110,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
111,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
112,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
113,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
113,2,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
114,1,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
115,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
116,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
116,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
117,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
117,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
117,4,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
118,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
119,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
119,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
120,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
120,3,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
120,4,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
121,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
122,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
122,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
122,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
123,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
127,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
128,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
129,1,Headache,Headaches NEC,Headaches,Nerv,N
129,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
130,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
131,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
131,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
132,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
133,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
133,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
134,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
136,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
136,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
136,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
137,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,2,Headache,Headaches NEC,Headaches,Nerv,N
137,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
138,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
139,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
140,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
140,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,1,Headache,Headaches NEC,Headaches,Nerv,N
142,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
143,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
144,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
146,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
147,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
147,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Headache,Headaches NEC,Headaches,Nerv,N
149,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
149,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
150,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
151,1,Headache,Headaches NEC,Headaches,Nerv,N
151,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
151,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
151,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
151,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
153,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
153,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
154,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
154,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
155,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
156,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
157,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
157,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
159,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
160,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
160,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
160,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
161,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
161,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
161,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
161,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
162,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
163,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
163,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
163,3,Headache,Headaches NEC,Headaches,Nerv,N
163,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
163,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
163,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
164,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
166,1,Headache,Headaches NEC,Headaches,Nerv,N
167,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
168,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
168,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
169,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
170,1,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
171,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
172,1,Deafness,Hearing losses,Hearing disorders,Ear,N
172,2,Eosinophilic otitis media,Middle ear infections and inflammations,Middle ear disorders (excl congenital),Ear,N
173,1,Immune-mediated cystitis,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
174,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
176,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
176,2,Headache,Headaches NEC,Headaches,Nerv,N
176,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
176,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
178,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
178,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
178,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
178,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
179,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
179,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,3,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
179,4,Migraine,Migraine headaches,Headaches,Nerv,N
180,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
180,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
181,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
182,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
182,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
184,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
185,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
185,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
187,1,Headache,Headaches NEC,Headaches,Nerv,N
188,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
188,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
190,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
191,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
192,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
193,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
194,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
194,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
195,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
196,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
196,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
197,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
197,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
197,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
198,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
199,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
199,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
199,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
199,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
201,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
202,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
203,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
204,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
206,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
206,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
207,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
207,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
208,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
209,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
209,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
210,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
210,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
211,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
211,2,Headache,Headaches NEC,Headaches,Nerv,N
211,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,4,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
212,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
212,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
213,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
214,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
215,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
217,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
218,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
219,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
219,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
220,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
220,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
220,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
221,1,Headache,Headaches NEC,Headaches,Nerv,N
222,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
222,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
222,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
223,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
224,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
225,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
226,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
226,2,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
227,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
227,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
228,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
229,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
230,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
231,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
231,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
233,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
233,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
235,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
236,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
236,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
237,1,Deafness,Hearing losses,Hearing disorders,Ear,N
238,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
239,1,Headache,Headaches NEC,Headaches,Nerv,N
240,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
241,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,1,Headache,Headaches NEC,Headaches,Nerv,N
242,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
242,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
242,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
243,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
244,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
244,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
244,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
245,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
245,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
245,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
245,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
246,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
247,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
247,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
248,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
249,1,Headache,Headaches NEC,Headaches,Nerv,N
250,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
251,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
251,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
252,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
253,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
253,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
253,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
253,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
254,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
254,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
255,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
256,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
257,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
258,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
259,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,2,Headache,Headaches NEC,Headaches,Nerv,N
259,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
259,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
259,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
259,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
260,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
261,1,Headache,Headaches NEC,Headaches,Nerv,N
261,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
262,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
263,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
264,1,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
265,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
267,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
268,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
269,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
269,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
270,1,Headache,Headaches NEC,Headaches,Nerv,N
271,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
272,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
273,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
273,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
275,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
275,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
276,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
277,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
278,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
279,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
279,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
280,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
280,2,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
281,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
283,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
283,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,1,Tension headache,Headaches NEC,Headaches,Nerv,N
285,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
286,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
287,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
287,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
287,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
289,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
290,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
290,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
290,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
292,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,1,Eosinophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
295,1,Headache,Headaches NEC,Headaches,Nerv,N
296,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
296,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
298,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
299,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
300,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
301,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
301,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
301,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
302,1,Headache,Headaches NEC,Headaches,Nerv,N
302,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
303,1,Headache,Headaches NEC,Headaches,Nerv,N
303,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
303,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
304,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
304,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
304,3,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
305,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
305,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
305,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
307,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
307,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
308,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
308,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
308,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
308,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
309,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
310,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
311,1,COVID-19 immunisation,Immunisations,Therapeutic procedures and supportive care NEC,Surg,N
311,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
312,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
312,2,Headache,Headaches NEC,Headaches,Nerv,N
312,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
312,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
313,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
314,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
315,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
316,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
317,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
317,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
319,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
319,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
320,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
320,3,Sensitivity to weather change,General signs and symptoms NEC,General system disorders NEC,Genrl,N
321,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
321,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Headache,Headaches NEC,Headaches,Nerv,N
322,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
322,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
324,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
324,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
325,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
326,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
327,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
327,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
328,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
329,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
330,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
330,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
331,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
332,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
332,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
333,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
334,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
334,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
335,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
336,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
337,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
338,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
338,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
339,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
340,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
341,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
342,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
342,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
343,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
344,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
345,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
345,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
347,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
347,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
347,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
347,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
348,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
349,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
350,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
351,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
351,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
351,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
352,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
352,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,2,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
353,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
354,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
354,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
355,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
355,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
355,3,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
355,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
355,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
356,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
356,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
356,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
357,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
357,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
359,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
359,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
360,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
361,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
361,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
362,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
362,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
362,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
363,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
363,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
364,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
364,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
365,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
366,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
367,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
368,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
369,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
370,1,Headache,Headaches NEC,Headaches,Nerv,N
371,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
372,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
372,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
373,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
374,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
374,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
376,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
377,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
377,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
377,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
378,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
378,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
378,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
378,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
379,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
381,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
382,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
383,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
383,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
384,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
385,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
385,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
385,3,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
386,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
386,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
387,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
388,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
388,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
389,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
390,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
390,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
391,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
391,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
392,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
393,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
393,2,Cerebrospinal fluid retention,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
394,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
394,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
395,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
395,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
396,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
396,3,Headache,Headaches NEC,Headaches,Nerv,N
397,1,Eosinopenia,Leukopenias NEC,White blood cell disorders,Blood,N
397,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
398,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
399,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
399,2,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
399,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
400,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
400,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
400,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
402,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
402,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
403,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
404,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
404,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
405,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
406,1,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
407,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
408,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
408,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
408,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
408,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
409,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
410,1,Migraine,Migraine headaches,Headaches,Nerv,N
411,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
412,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
412,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,1,Headache,Headaches NEC,Headaches,Nerv,N
414,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
415,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
416,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
416,2,Headache,Headaches NEC,Headaches,Nerv,N
417,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
417,2,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
417,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
418,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
418,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
419,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
419,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
419,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
419,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
419,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
420,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
421,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
422,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
422,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
422,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
422,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
422,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
422,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
422,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
423,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
423,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
423,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
423,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
424,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
425,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
426,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
427,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
427,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
428,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
429,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
429,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
430,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
430,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
430,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
431,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
432,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
432,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
433,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
433,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
434,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
434,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
434,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
435,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
436,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
437,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
437,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
438,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
439,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
439,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
439,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
440,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
441,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
441,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
442,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
442,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
443,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
444,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
444,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
445,1,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
446,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
447,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
447,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
447,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
447,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
448,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
448,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
448,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
449,1,Headache,Headaches NEC,Headaches,Nerv,N
450,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
450,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
451,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
451,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
452,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
452,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,1,Lower respiratory tract congestion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
454,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
454,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
454,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
455,1,Acne,Acnes,Skin appendage conditions,Skin,N
455,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
455,3,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
455,4,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
455,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
455,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
455,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
456,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
456,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
458,1,Headache,Headaches NEC,Headaches,Nerv,N
458,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
459,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
459,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
460,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
461,1,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
462,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
463,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
463,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
463,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
464,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
464,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
465,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
465,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
466,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
468,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
469,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
470,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
471,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
472,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
472,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
472,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
472,4,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
472,5,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
472,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
473,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
474,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
475,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
476,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
476,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
477,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
478,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
479,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
480,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
481,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
481,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
482,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
483,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
483,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
484,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
485,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
485,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
485,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
485,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
486,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
486,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
486,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
486,8,Headache,Headaches NEC,Headaches,Nerv,N
486,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
486,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
486,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
486,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
487,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
487,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
487,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
488,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
490,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
491,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
492,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
492,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
494,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
494,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
495,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
496,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
497,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
498,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
499,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
500,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
500,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
501,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
502,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
502,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
503,1,Headache,Headaches NEC,Headaches,Nerv,N
503,2,Sinus headache,Headaches NEC,Headaches,Nerv,N
504,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
504,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
504,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
505,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
506,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
506,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
506,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,4,Headache,Headaches NEC,Headaches,Nerv,N
506,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
506,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
506,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
506,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
506,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
506,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
507,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
507,2,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
508,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
509,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
509,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
510,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
511,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
512,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
513,2,Headache,Headaches NEC,Headaches,Nerv,N
513,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
514,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
514,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
514,3,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
514,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
514,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
515,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
516,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
516,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
516,3,Headache,Headaches NEC,Headaches,Nerv,N
516,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
517,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
517,2,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
517,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
518,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
519,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
519,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
519,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,1,Asthma prophylaxis,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
521,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
521,2,Device leakage,Device issues NEC,Device issues,Prod,N
521,3,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
521,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
522,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
523,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
523,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
524,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
524,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
524,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
524,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
524,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
525,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
525,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
525,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
526,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
526,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
526,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
526,4,Headache,Headaches NEC,Headaches,Nerv,N
526,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
526,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
527,1,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
528,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
528,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
529,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
529,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
529,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
530,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
531,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
533,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
533,2,Migraine,Migraine headaches,Headaches,Nerv,N
534,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
535,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
536,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
536,2,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
537,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
537,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
537,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
538,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
538,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
538,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
538,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
539,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
540,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
540,2,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
540,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
541,1,Headache,Headaches NEC,Headaches,Nerv,N
542,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
543,1,Headache,Headaches NEC,Headaches,Nerv,N
544,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
544,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
544,3,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
544,4,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
545,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
546,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
546,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
546,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
547,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
547,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
548,1,Headache,Headaches NEC,Headaches,Nerv,N
549,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
550,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
551,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
552,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
552,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
553,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
554,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,2,Headache,Headaches NEC,Headaches,Nerv,N
555,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
556,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
557,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
557,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
558,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
559,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
559,2,Headache,Headaches NEC,Headaches,Nerv,N
559,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
560,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
561,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
561,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
562,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
563,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
563,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
563,3,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
564,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
565,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
566,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
567,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
568,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
569,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
570,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
570,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
570,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
571,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
572,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
572,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
573,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
574,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
575,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
576,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
576,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
576,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
576,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
577,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
577,2,Headache,Headaches NEC,Headaches,Nerv,N
578,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
579,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
580,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
581,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
581,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
581,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
582,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
583,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
584,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
584,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
586,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
586,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
587,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
587,2,Headache,Headaches NEC,Headaches,Nerv,N
587,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
588,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
589,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
589,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
590,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
591,1,Fractional exhaled nitric oxide increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
592,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
592,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
592,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
593,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
594,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
595,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
596,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
597,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
598,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
599,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
600,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
601,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
602,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
602,3,Headache,Headaches NEC,Headaches,Nerv,N
603,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
603,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
604,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
604,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
604,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
604,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
605,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
606,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
607,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
608,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
608,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
608,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
609,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
609,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
610,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
611,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
612,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
613,1,Eosinophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
614,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
614,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
614,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
614,4,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
614,5,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
615,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
616,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
616,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
616,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
617,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
617,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
617,4,Neutralising antibodies positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
618,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
619,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
620,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
620,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
621,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
622,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
622,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
622,3,Headache,Headaches NEC,Headaches,Nerv,N
623,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
624,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
625,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
625,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
626,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
628,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
629,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
629,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
631,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
631,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
632,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
633,1,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
634,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
635,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
